UroUpdate (@uroupdate) header
UroUpdate (@uroupdate) profile picture
Deutschland
Joined June 2015
Photo by UroUpdate (@uroupdate)Photo by UroUpdate (@uroupdate)Photo by UroUpdate (@uroupdate)Photo by UroUpdate (@uroupdate)Photo by UroUpdate (@uroupdate)Photo by UroUpdate (@uroupdate)Photo by UroUpdate (@uroupdate)Photo by UroUpdate (@uroupdate)Photo by UroUpdate (@uroupdate)Photo by UroUpdate (@uroupdate)
UroUpdate retweeted
ASCO 2026 | Prostatakarzinom Prof. Dr. Axel S. Merseburger zieht Bilanz zum diesjährigen Kongress und diskutiert die wichtigsten Entwicklungen beim Prostatakarzinom. ▶️ Jetzt das Wrap-up ansehen. @amerseburger #ASCO26 #Prostatakarzinom #Uroonkologie #onkowissentv
2
4
4
804
UroUpdate retweeted
#Update26 Programm ⬇️ Top-Fortbildung, spannende Diskussionen und echtes Update-Wissen für die tägliche Praxis. uro-update.com/ #UroUpdate2026 #UroUpdate #Urologie #Fortbildung #MedUpdate #Onkologie #UroOnkologie #CME #Berlin
4
4
324
🚨 The latest issue of touchREVIEWS in Oncology & Haematology is here! Explore expert insights on lymphoma, melanoma, lung & biliary cancers, leukaemia, and more. 🧬 Read now: touchoncology.com/journals/t… #Oncology #Haematology #CancerResearch #MedicalEducation #Lymphoma #Melanoma
4
5
323
🌟The future of oncology starts here! We’re proud to launch touchONCOLOGY Future Leaders 2025—celebrating rising stars touchoncology.com/insight/in… @andradaturcas @AriRosenbergMD @EMariamidze @EricLanderMD @mnoncology @JArakelyan28092 @poojaghatalia @FoxChaseCancer @BrasilOncologia
5
6
354
🚨 TODAY! Get the latest updates on mHSPC! 🏥 Dive into novel treatment strategies, strengthen MDT collaboration, and refine care pathways for better patient outcomes. 🎯 Don't miss out! 🔗 Learn more: ms.spr.ly/6013qRltx #mHSPC @amerseburger @AlbertoBossial @Ecastromarcos
2
3
206
Honored to be mentioned by my mentor Prof. Vinata Lokeshwar in her great article on: "Natural history of bladder cancer: Validation of the multiple pathway ..." @OncoAlert @Uroweb @UKSH_KI_HL sciencedirect.com/science/ar… – at Frankfurt on the Main, Germany
1
15
48
5,054
⚡️PCa Oral Abstract Session⚡️ Final OS w/ TALA + ENZA as 1L Tx in unselected pts with mCRPC in the Ph 3 TALAPRO-2 trial @neerajaiims @urotoday #medicalavatar #prostatecancer #GU25 @medudy_com @nataliagandur @bavilima @wandering_gu @DrYukselUrun @alison_tree @CaPsurvivorship @montypal @zklaassen_md @NazliDizman @declangmurphy @AzadOncology @scserendipity1 @UKSH_KI_HL @ – at San Francisco, CA
1
6
1
24
1,841
Looking forward meeting @ProfHadaschik @ProfKHerrmann @grimm_mo @BellevilleErik at poster L27 "Prostate Cancer Real World Evidence Registry (PROCARE): Recurrent and metastatic prostate cancer" Study aims to enroll 5,000 patients in Germany #GU25 #ASCOGU25 #mHSPC #mCRPC @OncoAlert
7
16
1,723
🚀 Who are the top oncologists leading the digital conversation? 📢 Check out this ranking of digital thought leaders in oncology based on their Twitter following! 📊 Notably, female oncologists highlighted in green! 👇 #MedTwitter #GU25 #ASCOGU25 @brunolarvol @OncoAlert
5
21
3
59
12,498
50%HR 0.69
44%HR 0.79
7%HR 0.89
107 votes • Final results
3
12
28
3,715
📹 Watch this roundtable discussion with a multi-disciplinary panel moderated by Prof. @amerseburger . They review a difficult metastatic case involving a 72-year-old with biochemical recurrence, oligometastatic disease. Learn more here 👇 prostate.uroonco.uroweb.org/…
4
1
8
1,179
A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24 LINK TO ARTICLE👇👇👇👇👇👇👇👇 sciencedirect.com/science/ar… NOW ON FINAL SESSION of #PROSCA24 The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in prostate cancer management while underscoring areas where high-quality evidence is still lacking. The conference gathered expert opinions on controversial clinical issues, particularly in advanced prostate cancer, offering guidance in cases where guidelines are unclear or conflicting. The report emphasizes personalized treatment approaches, considering patient-specific factors and evolving clinical data, and stresses the importance of ongoing clinical trials to fill knowledge gaps. It provides a practical framework for physicians and patients to engage in shared decision-making, especially in complex cases of high-risk localized and locally advanced prostate cancer. Our Thanks to all authors: @Silke_Gillessen @fabioturco92 @Prof_IanD @drjefstathiou Karim Fizazi @Prof_Nick_James Neal Shore Eric Small Matthew Smith @ChrisSweens1 @BertrandTOMBAL @ZilliThomas @neerajaiims Emmanuel S. Antonarakis Ana Aparicio Andrew J. Armstrong Diogo Assed Bastos Gerhardt Attard Karol Axcrona Mouna Ayadi Himisha Beltran @bjartell @PBlanchardMD @BourlonMaite @Albert0Briganti Muhammad Bulbul Consuelo Buttigliero Orazio Caffo @cdanicas @Ecastromarcos Heather H. Cheng Kim N. Chi Caroline S. Clarke Noel Clarke Johann S. de Bono @mdesantis234 @nachoduranm @EfstathiouEleni Onyeanunam N. Ekeke Tamer I.H. El Nahas @drlouiseemmett @stefanofanti4 Omolara A. Fatiregun Felix Y. Feng Peter C.C. Fong @fontev1 @Nicola_Fossati Daniel J. George @marty_gleave Gwenaelle Gravis Susan Halabi Daniel Heinrich @ProfKHerrmann @DrMHofman Thomas A. Hope Lisa G. Horvath Maha H.A. Hussain @BarbaraJereczek Robert J. Jones Anthony M. Joshua @ravikanesvaran Daniel Keizman @FacsRaja Gero Kramer @LoebStacy Brandon A. Mahal Fernando C. Maluf 75 76, @quimmateo David Matheson 78, Mika P. Matikainen 79, Ray McDermott 80, @DrRanaMcKay Niven Mehra 82, @amerseburger @CaPsurvivorship Michael J. Morris 85, Hind Mrabti 86, Deborah Mukherji @declangmurphy Vedang Murthy Shingai B.A. Mutambirwa @DrPaulNguyen @WilliamOhMD @piet_ost Joe M. O’Sullivan Anwar R. Padhani Chris Parker Darren M.C. Poon Colin C. Pritchard Danny M Rabah Dana Rathkopf Robert E. Reiter Raphaele Renard-Penna Charles J. Ryan Fred Saad Juan Pablo Sade Shahneen Sandhu Oliver A. Sartor Edward Schaeffer Howard I. Scher Nima Sharifi Iwona A. Skoneczna Howard R. Soule @DrSpratticus Sandy Srinivas @cnsternberg Hiroyoshi Suzuki Mary-Ellen Taplin Camilla Thellenberg-Karlsson Derya Tilki Levent N. Türkeri Hiroji Uemura @DrYukselUrun Claire L. Vale Neha Vapiwala Jochen Walz Kosj Yamoah Dingwei Ye Evan Y. Yu Almudena Zapatero @AOmlin
8
95
7
182
30,557
Just in 👉 @BJUIjournal in this post hoc analysis of TITAN we show, that patients with the deepest PSA decline derived the greatest benefit in #mHSPC #ProstateCancer Link: bjui-journals.onlinelibrary.… @urotoday @OncoAlert @Uroweb
2
17
2
49
5,030
Honored to present #AVENGER study results #EMUC24 - full story just submitted for publication @EUplatinum @AdvancesTherapy @Uroweb @UKSH_KI_HL @ch_ohlmann
4
6
1
60
6,568
Honored to share my Urologist’s perspective at ESMO-SIOG: Working together in the era of personalized care for older adults with cancer session Join us on Monday, 16 Sep 2024 - 08:30 - 10:00 Toledo Auditorium - Hall 3 @myESMO @OncoAlert #ESMO24 @ravikanesvaran #mHSPC
12
2
26
3,766
Fantastic start of #APCCC perfect also in virtual format for the ones that couldn’t make it to #Lugano #Apccc24 @APCCC_Lugano @Silke_Gillessen @AOmlin @OncoAlert @ZilliThomas @Tilki_De @cdanicas @DrRanaMcKay @piet_ost @nataliagandur @dmukherji @neerajaiims @ravikanesvaran – at Yokohama-shi Kanagawa, Kanagawa
16
42
2,454
Great start of #EAU24 catching up with friends and colleges. Congrats 👏🏼 to EAU team for smooth start and all hard work @Uroweb @OncoAlert @urotoday @AStenzl @MariaJRibal @NDowJames @MRoupret
6
62
3,269